Welcure Drugs & Pharmaceuticals Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2018. For the quarter, the company's total revenue was INR 0.215 million. Profit was INR 0.138 million. Basic and diluted earnings per share was INR 0.01. For the nine months, the company's total revenue was INR 0.795 million. Profit was INR 0.134 million compared to loss of INR 0.026 million a year ago. Basic and diluted earnings per share was INR 0.01.